Steris: revenue, profit and dividends

In fiscal 2026, Steris had revenue of $5.94B, up 10.2% a year on average since 2016, and net income of $782M (13.2% of revenue). Its dividend per share has gone up 15 years in a row, to $2.46. It has 39% more shares than in 2016.

Revenue, fiscal 2026

$5.94B+10.2% a year

average annual revenue growth since 2016 · +8.7% vs 2025

Net income, 2026

$782M

13.2% of revenue

Diluted EPS, 2026

$7.93

17.7% a year since 2016

Dividend per share, 2026

$2.46

raised 15 years in a row

Revenue growth, 5 years

13.8% a year

since 2021

Shares, 2026

98.7M

+38.7% since 2016

Free cash flow, 2026

$972M

$1.34B from operations − $369M capex

Ticker: STE · NYSE
Sector: Health Care
Sub-industry: Health Care Equipment
Headquarters: Dublin, Ireland
Founded: 1985
In the S&P 500 since: December 23, 2019
Latest fiscal year: 2026, ended March 31, 2026
SEC filer: STERIS plc · CIK 0001757898

Revenue and net income

Revenue went from $1.3B in 2009 to $5.94B in 2026.

RevenueNet income

Fiscal years · US dollarsSource: SEC EDGAR (company filings)

Diluted earnings per share

Diluted EPS went from $1.86 in 2009 to $7.93 in 2026. Ten-year growth: 17.7% a year.

Fiscal years · US dollars per share, adjusted for splitsSource: SEC EDGAR (company filings)

Dividends per share

Raised 15 years in a row, every year from 2012 to 2026. Ten-year growth: 9.6% a year.

Fiscal years · US dollars per share, adjusted for splitsSource: SEC EDGAR (company filings)

Shares outstanding

38.7% more shares in 2026 than in 2016 (71.2M → 98.7M): new shares outweighed buybacks.

Fiscal years · diluted weighted-average shares, adjusted for splitsSource: SEC EDGAR (company filings)

Operating cash flow, capex and free cash flow

Free cash flow (operating cash flow minus capital expenditure) was $972M in 2026, 16.4% of revenue.

Operating cash flowCapital expenditureFree cash flow

Fiscal years · US dollarsSource: SEC EDGAR (company filings)

Year by year

Fiscal year	Revenue	Net income	Net margin	Diluted EPS	Dividend	Shares	Operating cash flow	Capex	Free cash flow
2026	$5.94B	$782M	13.2%	$7.93	$2.46	98.7M	$1.34B	$369M	$972M
2025	$5.46B	$615M	11.3%	$6.20	$2.23	99.1M	$1.15B	$370M	$778M
2024	$5.14B	$378M	7.4%	$3.81	$2.03	99.4M	$973M	$360M	$613M
2023	$4.54B	$107M	2.4%	$1.07	$1.84	100M	$757M	$362M	$395M
2022	$4.22B	$244M	5.8%	$2.48	$1.69	98.3M	$685M	$288M	$397M
2021	$3.11B	$397M	12.8%	$4.63	$1.57	85.9M	$690M	$239M	$450M
2020	$3.03B	$408M	13.5%	$4.76	$1.45	85.6M	$591M	$215M	$376M
2019	$2.78B	$304M	10.9%	$3.55	$1.33	85.5M	$540M	$190M	$350M
2018	$2.62B	$291M	11.1%	$3.39	$1.21	85.7M	$458M	$165M	$292M
2017	$2.61B	$110M	4.2%	$1.28	$1.09	86.1M	$424M	$173M	$251M
2016	$2.24B	$111M	4.9%	$1.56	$0.98	71.2M	$255M	$126M	$128M
2015	$1.85B	$135M	7.3%	$2.25	$0.90	60M	$246M	$85.3M	$161M
2014	$1.62B	$129M	8.0%	$2.17	$0.82	59.7M	$210M	$86.4M	$123M
2013	$1.5B	$160M	10.7%	$2.72	$0.74	58.8M	$228M	$87.4M	$140M
2012	$1.41B	$136M	9.7%	$2.31	$0.66	59M	$149M	$66.7M	$82.7M
2011	$1.21B	$51.3M	4.2%	$0.85	$0.56	60.1M	$118M	$77.4M	$40.3M
2010	$1.26B	$128M	10.2%	$2.16	$2.44	59.4M	$225M	$44.1M	$181M
2009	$1.3B	$111M	8.5%	$1.86	—	—	$167M	$40.9M	$126M

Fiscal years, labelled by the year in which they end. US dollars; per-share figures and share counts adjusted for splits. —: not in the data.

About these figures

Figures filed before May 30, 2019 come from STERIS plc (CIK 0001624899), the earlier SEC registrant of the same business.
Figures filed before February 9, 2016 come from Steris Corp (CIK 0000815065), the earlier SEC registrant of the same business.
Older years are as filed at the time and may predate later restatements, mergers or spin-offs. How the figures are made.